Investigation of ovarian cancer associated sialylation changes in N-linked glycopeptides by quantitative proteomics
{{output}}
Background: In approximately 80% of patients, ovarian cancer is diagnosed when the patient is already in the advanced stages of the disease. CA125 is currently used as the marker for ovarian cancer; however, it lacks specificity ... ...
